Last updated on November 2016

A 12-Week Phase 2 Study of Gemcabene in Hypercholesterolemia Patients on Stable Moderate and High-Intensity Statins


Brief description of study

The purpose of this study is to assess the efficacy, safety, and tolerability of multiple doses of gemcabene 600 mg QD compared to placebo in patients with hypercholesterolemia not adequately controlled on high-intensity or moderate-intensity stable statin therapy. Patients with HeFH, ASCVD, or otherwise uncontrolled, may be included with baseline LDL-C value ≥ 100 mg/dL. Subjects will be randomized 1:1 to gemcabene 600 mg QD or placebo.

Clinical Study Identifier: NCT02634151

Find a site near you

Start Over

Mid-Hudson Medical Research

New Windsor, NY United States
  Connect »

National Research Institute

Huntington Park, CA United States
  Connect »

National Research Institute

Los Angeles, CA United States
  Connect »

Excel Medical Clinical Trials

Boca Raton, FL United States
  Connect »

Health Awareness, Inc.

Jupiter, FL United States
  Connect »

Meridien Research, Inc.

Maitland, FL United States
  Connect »

Progressive Medical Research

Port Orange, FL United States
  Connect »

Varkey Medical

Tampa, FL United States
  Connect »

L-MARC

Louisville, KY United States
  Connect »

Sterling Research Group, Ltd.

Cincinnati, OH United States
  Connect »

Associates in Medicine

Houston, TX United States
  Connect »

Diagnostics Research Grup

San Antonio, TX United States
  Connect »

Sugar Lakes Family Practice

Sugar Land, TX United States
  Connect »

National Research Institute

Richmond, VA United States
  Connect »